• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors





Thomas Whiting, MPA

Latest:

There's More Than One Way to Build a Medical Home

Even among practices reaching the highest level of PCMH achievement, there are variations in the implementation of key medical home capabilities.



Alex Mutebi, PhD, MSc

Latest:

Two-Year Adherence and Costs for Biologic Therapy for Rheumatoid Arthritis

Adherence to newly initiated biologic therapy for rheumatoid arthritis is important for long-term adherence.


Kevin Komoto, PharmD, MBA

Latest:

Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions

Patients receiving postdischarge care from pharmacists had a 28% lower risk of readmission at 30 days and a 31.9% lower risk at 180 days compared with usual care.


Diana Anderson, EdM

Latest:

IT-Enabled Systems Engineering Approach to Monitoring and Reducing ADEs

Self-empowering team resource management, when aided by information technology, appears to help reduce adverse drug events in primary care offices.







Lisa Bloudek, PharmD, MS

Latest:

Costs Associated With Long-Acting Insulin Analogues in Patients With Diabetes

Findings from a literature review indicate that overall costs of long-acting insulin analogues are not significantly different from those of intermediate-acting human insulin and oral antidiabetic agents.





Zachary Predmore, BA

Latest:

Knowledge Gaps Inhibit Health IT Development for Coordinating Complex Patients' Care

This study examines the leading edge of health information technology used to coordinate the care of complex patients.



Alexis S. Gilroy, JD

Latest:

Incorporating Telemedicine as Part of COVID-19 Outbreak Response Systems

Healthcare providers should revisit disaster response policies to incorporate telemedicine systems to address some of the unique challenges posed by infectious disease outbreaks such as coronavirus disease 2019 (COVID-19).


David Dreyfus, DBA

Latest:

Costs and Spillover Effects of Private Insurers' Coverage of Hepatitis C Treatment

Expanding private-payer coverage of hepatitis C treatment may yield significant long-term cost savings for private payers, reduced costs to Medicare, and increased social value.



James J. Choi, PhD

Latest:

Testimonials Do Not Convert Patients From Brand to Generic Medication

We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.





John P. Keats, MD, National Medical Director for Affordability

Latest:

Curtailing Utilization of Low-Value Medical Care

Working together to reduce low-value care, stakeholders can help eliminate wasteful spending and deliver on their goal to improve the health of Americans by delivering higher-quality care at lower cost.


Chi-Chen Chen, MS

Latest:

A Pay-for-Performance Program for Diabetes Care in Taiwan: A Preliminary Assessment

A pay-for-performance program in Taiwan improved the quality of diabetes care and slightly increased the cost of care.



Rachel Roiland, PhD

Latest:

Using the NQF Measure Incubator to Develop Patient-Reported Outcome Performance Measures in Palliative Cancer Care

The National Quality Forum (NQF) Measure Incubator provides a platform for the development of patient-reported outcome performance measures in palliative cancer care, which is essential to understanding a cancer patient’s functional status and well being.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.